Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 378a (miR-378a) is a highly conserved small non-coding RNA belonging to the microRNA family and is encoded in the first intron of the PPARGC1B gene. It is processed into two mature strands, miR-378a-3p and miR-378a-5p, both of which participate in the post-transcriptional regulation of gene expression. miR-378a plays key roles in regulating energy metabolism, mitochondrial function, autophagy, and differentiation, and displays critical effects on cancer biology by influencing proliferation, migration, invasion, apoptosis, and angiogenesis. It has been implicated in a variety of diseases, including several cancers (where it acts as both an oncogene and tumor suppressor depending on the tissue and context), type 2 diabetes, obesity, cardiovascular disease, and liver fibrosis. miR-378a is currently studied as a potential therapeutic target and biomarker, with experimental strategies including synthetic inhibitors, mimics, and RNA-loaded nanoparticles being evaluated for disease treatment or management[1][3][5].
miR-378a inhibitors: block miR-378a function, altering expression of downstream targets to influence apoptosis, proliferation, and metabolism[1] miR-378a mimics: restore or enhance miR-378a activity to regulate gene expression involved in metabolic homeostasis, tumor growth, or fibrosis[1] Molecular sponges (circRNAs/lncRNAs): sequester miR-378a to modulate its biological effects[3]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 378a (miR-378a).